Trials / Completed
CompletedNCT01647997
Lactate Metabolism After an Endotoxin Challenge in Healthy Humans
Effects of an Acute Administration of Bacterial Endotoxin on Whole Body and Regional Lactate Metabolism in Healthy Male Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Lausanne · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Sepsis is characterized by hyperlactatemia, the severity of which is proportionate with sepsis severity. The pathophysiological mechanisms (increased lactate production vs decreased lactate utilization; tissues involved in sepsis-induced lactate production) remain largely unknown. In this study, the investigators will assess whole body and regional metabolism in healthy young male subjects on two occasions, once after administration of an intravenous bacterial endotoxin challenge, and once without intervention. In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge * Energy expenditure and net substrate oxidation rates (indirect calorimetry) * Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion) * Glucose kinetics (measured with 6,6 d2 glucose) * Hemodynamic parameters and body temperature * Blood clinical chemistry In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge * Energy expenditure and net substrate oxidation rates (indirect calorimetry) * Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion) * Glucose kinetics (measured with 6,6 d2 glucose) * Hemodynamic parameters and body temperature * Blood clinical chemistry In a second group of subjects, regional muscle lactate metabolism will be measured over 10 hours after the endotoxin challenge by means of muscle microdialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bacterial endotoxin challenge | iv administration of 2ng/kg bacterial endotoxin |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2004-03-01
- Completion
- 2004-12-01
- First posted
- 2012-07-24
- Last updated
- 2012-07-24
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01647997. Inclusion in this directory is not an endorsement.